Terms: = Kidney tumors AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1 AND Clinical Outcome
418 results:
1. Spreading Through Air Spaces And Thinking About Lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
2. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
3. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with clinical outcomes of Guillain-Barre Syndrome Variants.
Bano S; Nawaz A; Nasim A; Numan A; Zahid M
J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
[TBL] [Abstract] [Full Text] [Related]
4. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract] [Full Text] [Related]
5. Predictive and prognostic biomarkers in urological tumours.
Cimadamore A; Franzese C; Di Loreto C; Blanca A; Lopez-Beltran A; Crestani A; Giannarini G; Tan PH; Carneiro BA; El-Deiry WS; Montironi R; Cheng L
Pathology; 2024 Mar; 56(2):228-238. PubMed ID: 38199927
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics and clinical outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract] [Full Text] [Related]
7. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
[TBL] [Abstract] [Full Text] [Related]
8. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
9. Undernutrition risk is independently associated with worsened indicators of hospital rehabilitation in COVID-19 patients.
Pinheiro VE; Ribeiro AS; Camillo CAM; Casonatto J
Hosp Pract (1995); 2023 Dec; 51(5):267-274. PubMed ID: 37897431
[TBL] [Abstract] [Full Text] [Related]
10. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
[TBL] [Abstract] [Full Text] [Related]
11. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
12. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer.
Milane LS; Dolare S; Ren G; Amiji M
J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
[TBL] [Abstract] [Full Text] [Related]
13. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract] [Full Text] [Related]
14. Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab.
Matsumura S; Kato T; Kujime Y; Kitakaze H; Nakano K; Hongo S; Yoshioka I; Okumi M; Nonomura N; Takada S
BMC Urol; 2023 Jun; 23(1):107. PubMed ID: 37301837
[TBL] [Abstract] [Full Text] [Related]
15. Remarkable 107-year-old kidney with a 49-year of long-term allograph survival through continuous azathioprine monotherapy.
Nascimento E; Filho AS; Lucas-Junior FDM; Jobim LFJ; Lasmar MF; Tavares-Filho HA; Fabreti-Oliveira RA
Transpl Immunol; 2023 Jun; 78():101821. PubMed ID: 36921732
[TBL] [Abstract] [Full Text] [Related]
16. The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors.
Perrone F; Favari E; Maglietta G; Verzè M; Pluchino M; Minari R; Sabato R; Mazzaschi G; Ronca A; Rossi A; Cortellini A; Pecci F; Cantini L; Bersanelli M; Quaini F; Tiseo M; Buti S
Cancer Immunol Immunother; 2023 Jul; 72(7):2127-2135. PubMed ID: 36828963
[TBL] [Abstract] [Full Text] [Related]
17. Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.
Behrendt CE; Villalona-Calero MA; Newman EM; Frankel PH
Contemp Clin Trials; 2023 Feb; 125():107083. PubMed ID: 36638911
[TBL] [Abstract] [Full Text] [Related]
18. Differential Expression of RSK4 Transcript Isoforms in Cancer and Its clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts.
Konaté MM; Li MC; McShane LM; Zhao Y
Sci Rep; 2022 Nov; 12(1):19283. PubMed ID: 36369472
[TBL] [Abstract] [Full Text] [Related]
20. Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis.
Bek SG; Marschner S; Sud K; Johnson DW; Chow CK; Hawley C; Pilmore H; Wong G; Lim W; Lee VW
Nephrology (Carlton); 2023 Jan; 28(1):21-27. PubMed ID: 36222366
[TBL] [Abstract] [Full Text] [Related]
[Next]
